ImmunoCellular Therapeutics, Ltd. (IMUC)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
| Previous close | 0.1840 |
| Open | 0.2100 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 3000 |
| Day's range | 0.2100 - 0.2100 |
| 52-week range | 0.1100 - 0.4000 |
| Volume | |
| Avg. volume | 3,195 |
| Market cap | 23.787M |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | 0.02 |
| EPS (TTM) | 11.6700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireEOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.
© 2024 Yahoo. All rights reserved.